Brief: Clover Biopharmaceuticals Posts Loss For Year RMB6.02 Billion
29/03/2022 13:56
March 29 (Reuters) - Clover Biopharmaceuticals:
* LOSS FOR YEAR RMB6.02 BILLION VERSUS LOSS OF RMB912.9
MILLION
Source text for Eikon: ID:nHKS2dd1x8
Further company coverage: 2197.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clover Biopharmaceuticals
See all newsChina's Clover Biopharma H1 revenue drops sharply, flags going-concern doubt
Brief: Clover Biopharmaceuticals Posts FY Loss Of RMB205.1 MLN
Brief: Clover Announces Positive Phase I Clinical Data For Rsv-Hmpv-Piv3 Combination Vaccines And For Rsv Re-Vaccination In Older Adults
Brief: Clover Biopharmaceuticals Posts H1 Revenue Of RMB3.3 Million
Brief: Clover Biopharmaceuticals Says It Terminates Cooperation With Adimmune